Literature DB >> 20515922

Delineation of regions of the Yersinia YopM protein required for interaction with the RSK1 and PRK2 host kinases and their requirement for interleukin-10 production and virulence.

Joseph B McPhee1, Patricio Mena, James B Bliska.   

Abstract

The YopM protein of Yersinia sp. is a type III secreted effector that is required for virulence in murine models of infection. YopM has previously been shown to contain leucine-rich repeats (LRRs) and to interact with two host kinases, RSK1 and PRK2, although the consequence of these interactions is unknown. A series of YopM proteins missing different numbers of LRRs or a C-terminal domain were produced and used for in vitro binding reactions to map domains required for interaction with RSK1 and PRK2. A C-terminal domain of YopM (from LRR12 to the C terminus) was shown to be required for interaction with RSK1, while an internal portion encompassing LRR6 to LRR15 was shown to be required for interaction with PRK2. The virulence of a Yersinia pseudotuberculosis Delta yopM mutant in mice via an intravenous route of infection was significantly attenuated. At day 4 postinfection, there were significantly increased levels of gamma interferon and reduced levels of interleukin-18 (IL-18) and IL-10 in the serum of the Delta yopM-infected mice compared to that of mice infected with the wild type, suggesting that YopM action alters the balance of these key cytokines to promote virulence. The PRK2 and RSK1 interaction domains of YopM were both required for IL-10 induction in vivo, irrespective of splenic colonization levels. In an orogastric model of Y. pseudotuberculosis infection, a Delta yopM mutant was defective in dissemination from the intestine to the spleen and significantly reduced in virulence. In addition, Y. pseudotuberculosis mutants expressing YopM proteins unable to interact with either RSK1 (YopM Delta 12-C) or PRK2 (YopM Delta 6-15) were defective for virulence in this assay, indicating that both interaction domains are important for YopM to promote pathogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515922      PMCID: PMC2916259          DOI: 10.1128/IAI.00269-10

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  50 in total

Review 1.  The role of IL-18 in innate immunity.

Authors:  S Akira
Journal:  Curr Opin Immunol       Date:  2000-02       Impact factor: 7.486

Review 2.  Interleukin-18 (IL-18) and infectious diseases, with special emphasis on diseases induced by intracellular pathogens.

Authors:  I Sugawara
Journal:  Microbes Infect       Date:  2000-08       Impact factor: 2.700

3.  The RhoGAP activity of the Yersinia pseudotuberculosis cytotoxin YopE is required for antiphagocytic function and virulence.

Authors:  D S Black; J B Bliska
Journal:  Mol Microbiol       Date:  2000-08       Impact factor: 3.501

4.  Yersinia enterocolitica evasion of the host innate immune response by V antigen-induced IL-10 production of macrophages is abrogated in IL-10-deficient mice.

Authors:  Andreas Sing; Andreas Roggenkamp; Anna M Geiger; Jürgen Heesemann
Journal:  J Immunol       Date:  2002-02-01       Impact factor: 5.422

5.  The yersinia virulence factor YopM forms a novel protein complex with two cellular kinases.

Authors:  Christine McDonald; Panayiotis O Vacratsis; James B Bliska; Jack E Dixon
Journal:  J Biol Chem       Date:  2003-03-06       Impact factor: 5.157

6.  Structure-function analysis of Yersinia pestis YopM's interaction with alpha-thrombin to rule on its significance in systemic plague and to model YopM's mechanism of binding host proteins.

Authors:  J Hines; E Skrzypek; A V Kajava; S C Straley
Journal:  Microb Pathog       Date:  2001-04       Impact factor: 3.738

7.  Unusual molecular architecture of the Yersinia pestis cytotoxin YopM: a leucine-rich repeat protein with the shortest repeating unit.

Authors:  A G Evdokimov; D E Anderson; K M Routzahn; D S Waugh
Journal:  J Mol Biol       Date:  2001-09-28       Impact factor: 5.469

8.  Application of a Saccharomyces cerevisiae model to study requirements for trafficking of Yersinia pestis YopM in eucaryotic cells.

Authors:  Elbieta Skrzypek; Tanya Myers-Morales; Sidney W Whiteheart; Susan C Straley
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

9.  Crystal structure of the platelet glycoprotein Ib(alpha) N-terminal domain reveals an unmasking mechanism for receptor activation.

Authors:  Sarah Uff; Jeannine M Clemetson; Tim Harrison; Kenneth J Clemetson; Jonas Emsley
Journal:  J Biol Chem       Date:  2002-06-26       Impact factor: 5.157

10.  Gr1+ cells control growth of YopM-negative yersinia pestis during systemic plague.

Authors:  Zhan Ye; Edward J Kerschen; Donald A Cohen; Alan M Kaplan; Nico van Rooijen; Susan C Straley
Journal:  Infect Immun       Date:  2009-07-06       Impact factor: 3.441

View more
  41 in total

1.  A protective epitope in type III effector YopE is a major CD8 T cell antigen during primary infection with Yersinia pseudotuberculosis.

Authors:  Yue Zhang; Patricio Mena; Galina Romanov; Jr-Shiuan Lin; Stephen T Smiley; James B Bliska
Journal:  Infect Immun       Date:  2011-11-07       Impact factor: 3.441

2.  Cytotoxic necrotizing factor-Y boosts Yersinia effector translocation by activating Rac protein.

Authors:  Manuel Wolters; Erin C Boyle; Kerstin Lardong; Konrad Trülzsch; Anika Steffen; Klemens Rottner; Klaus Ruckdeschel; Martin Aepfelbacher
Journal:  J Biol Chem       Date:  2013-06-26       Impact factor: 5.157

3.  CagA of Helicobacter pylori interacts with and inhibits the serine-threonine kinase PRK2.

Authors:  Jyoti Prasad Mishra; David Cohen; Andrea Zamperone; Dragana Nesic; Anne Muesch; Markus Stein
Journal:  Cell Microbiol       Date:  2015-06-19       Impact factor: 3.715

Review 4.  Interleukin-10 and immunity against prokaryotic and eukaryotic intracellular pathogens.

Authors:  Joshua C Cyktor; Joanne Turner
Journal:  Infect Immun       Date:  2011-05-16       Impact factor: 3.441

Review 5.  Yersinia type III effectors perturb host innate immune responses.

Authors:  Khavong Pha; Lorena Navarro
Journal:  World J Biol Chem       Date:  2016-02-26

6.  Distribution and Evolution of Yersinia Leucine-Rich Repeat Proteins.

Authors:  Yueming Hu; He Huang; Xinjie Hui; Xi Cheng; Aaron P White; Zhendong Zhao; Yejun Wang
Journal:  Infect Immun       Date:  2016-07-21       Impact factor: 3.441

7.  Characterization of Pyrin Dephosphorylation and Inflammasome Activation in Macrophages as Triggered by the Yersinia Effectors YopE and YopT.

Authors:  Natasha P Medici; Maheen Rashid; James B Bliska
Journal:  Infect Immun       Date:  2019-02-21       Impact factor: 3.441

8.  The Yersinia virulence effector YopM binds caspase-1 to arrest inflammasome assembly and processing.

Authors:  Christopher N LaRock; Brad T Cookson
Journal:  Cell Host Microbe       Date:  2012-12-13       Impact factor: 21.023

9.  The Yersinia Virulence Factor YopM Hijacks Host Kinases to Inhibit Type III Effector-Triggered Activation of the Pyrin Inflammasome.

Authors:  Lawton K Chung; Yong Hwan Park; Yueting Zheng; Igor E Brodsky; Patrick Hearing; Daniel L Kastner; Jae Jin Chae; James B Bliska
Journal:  Cell Host Microbe       Date:  2016-08-25       Impact factor: 21.023

10.  Yersinia virulence factor YopM induces sustained RSK activation by interfering with dephosphorylation.

Authors:  Moritz Hentschke; Laura Berneking; Cristina Belmar Campos; Friedrich Buck; Klaus Ruckdeschel; Martin Aepfelbacher
Journal:  PLoS One       Date:  2010-10-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.